ARCHIVES

Scientific Misconduct: HHS To Change Role Of ORI In Response To Council Report

This article is from The Cancer Letter archive.

Vol. 25 No. 46 | December 3, 1999

Download PDF Visit The Full Archive

Related Articles

Also: NCCN Committee Reaffirms Clinical Guideline Covering Avastin for Breast Cancer Indication

July 22, 2011

Abrams, Tomaszewski To Co-Direct DCTD

June 10, 2011

A letter about FDA oncology consolidation reopens debate among cancer groups; FDA asks groups not to send letters, invites discussion.

June 4, 2004

Senate Orders OMB T Increase NIH FTEs, Drop Rules On Apportionment

September 19, 1986

DCBDC Advisors Table Gl SPORE Over Pancreatic Cancer Research Requirement

March 17, 1995

National Coalition for Cancer Research Formed To Support Reauthorization, l Research Budgets

April 19, 1985